表紙:COVID-19 (新型コロナウイルス感染症) - パイプラインの考察:2020年
市場調査レポート
商品コード
939927

COVID-19 (新型コロナウイルス感染症) - パイプラインの考察:2020年

COVID-19 (CoronaVirus) - Pipeline Insight, 2020

出版日: 受注後作成 | 発行: DelveInsight Business Research LLP | ページ情報: 英文 90 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.26円
COVID-19 (新型コロナウイルス感染症) - パイプラインの考察:2020年
出版日: 受注後作成
発行: DelveInsight Business Research LLP
ページ情報: 英文 90 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、COVID-19 (新型コロナウイルス感染症) 治療薬について調査分析し、現在のシナリオと成長の見通しについて、体系的な情報を提供しています。

目次

第1章 レポートのイントロダクション

第2章 COVID-19(新型コロナウイルス感染症):疾患の概要

第3章 パイプラインの見通し

  • COVID-19のパイプライン製品の概要

第4章 比較分析

第5章 COVID-19の臨床段階における治療製品

  • 医薬品:企業
    • 製品説明
    • 研究開発
    • 製品開発活動
  • その他の製品プロファイル

第6章 COVID-19の非臨床段階における治療製品

  • 医薬品:企業
    • 製品説明
    • 研究開発
    • 製品開発活動
  • その他の製品プロファイル

第7章 治療パイプライン分析

  • パイプライン分析:投与経路別
  • パイプライン分析:ステージ・投与経路別
  • パイプライン分析:分子タイプ別
  • パイプライン分析:ステージ・分子タイプ別

第8章 休止中のパイプライン製品

  • 医薬品の説明
    • 研究開発
    • 製品開発活動
    • 休止/中止の理由

第9章 付録

第10章 調査手法

第11章 コンサルティングサービス

第12章 免責事項

第13章 DelveInsightについて

図表

List Of Tables

  • Table 1: Total Pipeline Products for COVID-19(CoronaVirus)
  • Table 2: COVID-19(CoronaVirus) Therapeutic Products in Clinical Stage
  • Table 3: COVID-19(CoronaVirus) Therapeutic Products in Non-clinical Stage
  • Table 4: Pipeline Analysis by Route of Administration
  • Table 5: Pipeline Analysis by Stage and Route of Administration
  • Table 6: Pipeline Analysis by Molecule Type
  • Table 7: Pipeline Analysis by Stage and Molecule Type
  • Table 8: Inactive Products

List Of Figures

  • Figure 1: Total Products for COVID-19(CoronaVirus)
  • Figure 2: COVID-19(CoronaVirus) Therapeutic Products in Clinical Stage
  • Figure 3: COVID-19(CoronaVirus) Therapeutic Products in Non-clinical Stage
  • Figure 4: Pipeline Analysis by Route of Administration
  • Figure 5: Pipeline Analysis by Stage and Route of Administration
  • Figure 6: Pipeline Analysis by Molecule Type
  • Figure 7: Pipeline Analysis by Stage and Molecule Type
  • Figure 8: Inactive Products
目次

"COVID-19(CoronaVirus) - Pipeline Insight, 2020" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across COVID-19 (CoronaVirus). A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration and molecule type.

Products covered by Phase

  • Phase III, Phase II, Phase I
  • Pre-clinical & Discovery
  • Inactive (Discontinued and Dormant)

Overview of pipeline development activities for COVID-19(CoronaVirus)

Pipeline analysis of therapeutic drugs include but are not limited to drug description and development activities focusing on clinical and pre-clinical results, designations, collaborations & licensing deals, grants, technology and patent details.

Therapeutic segmentation of products for COVID-19(CoronaVirus)

The report comprises of comparative pipeline therapeutics assessment by development stage, therapy type, molecule type, and administration route across this indication.

Methodology

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight's team of industry experts.

Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report

  • Provides an overview of therapeutic pipeline activity for COVID-19(CoronaVirus) across the complete product development cycle including all clinical and non-clinical stages
  • It comprises of detailed profiles of COVID-19(CoronaVirus) therapeutic products with key coverage of developmental activities including licensing & collaboration deals, patents issued, designations, technologies and chemical information
  • Therapeutic assessment of the active pipeline products by stage, product type, molecule type, and route of administration
  • Coverage of dormant and discontinued pipeline projects across COVID-19(CoronaVirus)

Reasons to Buy

  • Establish a comprehensive understanding of the current pipeline scenario across COVID-19(CoronaVirus) to formulate effective R&D strategies
  • Assess challenges and opportunities that influence COVID-19(CoronaVirus) R&D
  • Gather impartial perspective of strategies of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
  • Identify the relationship between the product and use it for target finding, drug repurposing, and precision medicine
  • Devise in licensing and out licensing strategies by identifying prospective partners with progressing projects for COVID-19(CoronaVirus) to enhance and expand business potential and scope
  • Our extensive domain knowledge on therapy areas support the client in decision-making process regarding their therapeutic portfolio by identifying the reason behind the inactive or discontinued drugs

Table of Contents

1. Report Introduction

2. COVID-19(CoronaVirus) - Disease Overview

3. Pipeline Outlook

  • An Overview of Pipeline Products for COVID-19(CoronaVirus)

4. Comparative Analysis

5. COVID-19(CoronaVirus) Therapeutic Products in Clinical Stage

  • 5.1 Drug Name : Company Name
    • Product Description
    • Research and Development
    • Product Development Activities
  • Other product profiles in the detailed report.....

6. COVID-19(CoronaVirus) Therapeutic Products in Non-clinical Stage

  • 6.1 Drug Name : Company Name
    • Product Description
    • Research and Development
    • Product Development Activities
  • Other product profiles in the detailed report.....

7. Therapeutic Pipeline Analysis

  • Pipeline Analysis by Route of Administration
  • Pipeline Analysis by Stage and Route of Administration
  • Pipeline Analysis by Molecule Type
  • Pipeline Analysis by Stage and Molecule Type

8. Inactive Pipeline Products

  • 8.1 Drug Description
    • Research and Development Studies
    • Product Development Activities
    • Reason for dormancy/discontinuation

9. Appendix

10. Report Methodology

11. Consulting Services

12. Disclaimer

13. About DelveInsight

Note: Certain sections of the table of contents would vary according to the availability of information.